Loading…
Indian FMCG company selling personal care and healthcare brands including Boroplus, Navratna, Zandu and Fair and Handsome.
Indian FMCG company selling personal care and healthcare brands including Boroplus, Navratna, Zandu and Fair and Handsome.
Sells small-ticket everyday brands through a wide network of distributors and shops, with winter products like Boroplus and summer products like Navratna cooling oil and talc balancing the year. The Agarwal and Goenka families control it, and bought brands such as Zandu and Kesh King extended the range.
In one line: An Indian personal-care conglomerate, a smaller Unilever for skincare/ayurvedic brands.
Moat: narrow (brand, distribution). Strong rural distribution network and heritage brands in niche personal-care/ayurvedic categories.
Headquarters: Kolkata, India · Founded: 1974 · Employees: 5,447
Size Emami (EMAMILTD.NS) is an India Consumer Staples company (Household/Personal Care) with a market value of $1.80B, the 395th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹387.20 on 6 Nov 2026.
Performance Over six months the shares fell 14.8%, against -3.2% for the median peer and 0.0% for the India market (cap-weighted) — 5th lowest of 21 in its peer set.
Growth Revenue grew 2.8% over the last twelve months (peer median +5.0%); the operating margin is 20.4% (peer median 9.2%).
Valuation It trades at 21.4× forward earnings against a peer median of 20.3× (10th most expensive of 21).
Price implies For today's price to make sense, revenue must grow about 22% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +16 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
Capital Return on invested capital runs 6.7 points above its cost of capital (13.8% WACC).
Next results Next results expected around 14 Feb 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | ₹39.1B | ₹37.8B | ₹38.1B | ₹35.8B | ₹34.1B |
| Revenue growth | — | -1% | +6% | +5% | — |
| Gross profit | ₹20.3B | ₹18.8B | ₹18.9B | ₹17.3B | ₹15.0B |
| EBITDA | ₹9.76B | ₹9.79B | ₹10.4B | ₹9.65B | ₹8.73B |
| Net income | ₹7.48B | ₹7.75B | ₹8.06B | ₹7.24B | ₹6.40B |
| Free cash flow | n/a | ₹7.64B | ₹8.60B | ₹7.42B | ₹7.11B |
| Capital expenditure | n/a | ₹433M | ₹446M | ₹406M | ₹405M |
| Total debt | n/a | ₹1.62B | ₹898M | ₹940M | ₹905M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Emami EMAMILTD.NS | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% |
| Dabur India DABUR.NS | $7.13B | -19% | +9% | 15% | 32.1× | 27.3% |
| Hindustan Unilever HINDUNILVR.NS | $49.6B | -12% | +6% | 21% | 41.5× | 27.2% |
| Marico MARICO.NS | $12.3B | +8% | +20% | 16% | 51.8× | 28.0% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | EMAMILTD.NS | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +3.1% | +1.6% | 9th highest of 21 |
| 6-month return | -14.8% | -3.2% | 5th lowest of 21 |
| Distance from 52-week high | -29.7% | -24.0% | 10th lowest of 21 |
| Revenue growth (TTM) | +2.8% | +5.0% | 10th lowest of 21 |
| Operating margin | 20.4% | 9.2% | 5th highest of 21 |
| Forward P/E | 21.4× | 20.3× | 10th most expensive of 21 |
| Growth the price implies (Req g, 7 yrs) | 21.7% | 4.3% | 2nd most demanding of 17 |
| Growth delivered (Del g) | +5.6% | +5.5% | 9th highest of 17 |
| Hurdle (Req g minus delivered) | +16.1 pp | -2.8 pp | 2nd most demanding of 17 |
| ROIC minus cost of capital | +6.7 pp | +4.6 pp | 9th highest of 21 |
| EV / EBITDA | 17.4× | 11.5× | 3rd most expensive of 13 |
| Net debt / EBITDA | -0.8× | -0.5× | 7th least indebted of 14 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Emami EMAMILTD.NS | India | $1.80B | -15% | +3% | 20% | 21.4× | 21.7% | +5.6% |
| Yunnan Botanee Bio-Technology 300957.SZ | China | $1.84B | -28% | +7% | 9% | 21.2× | 4.5% | +15.3% |
| Shanghai Jahwa United 600315.SS | China | $1.74B | -13% | +9% | 2% | 18.1× | 17.1% | -2.1% |
| Blue Moon 6993.HK | Hong Kong | $1.88B | -15% | -2% | -2% | 93.6× | n/a | n/a |
| Kolmar Korea 161890.KS | South Korea | $1.89B | +23% | +13% | 10% | 13.0× | -0.9% | +15.5% |
| Pigeon 7956.T | Japan | $1.66B | +30% | +7% | 13% | 26.3× | -1.3% | +1.9% |
| Pola Orbis 4927.T | Japan | $1.96B | +8% | +1% | 10% | 28.8× | -3.1% | -0.7% |
| Energizer ENR | United States | $1.63B | +26% | +2% | 16% | 7.2× | -5.2% | +1.5% |
| Harbin Fuerjia Technology 301371.SZ | China | $1.58B | -30% | +28% | 20% | 22.5× | 8.7% | +3.6% |
| AMOREPACIFIC 002790.KS | South Korea | $1.55B | -3% | +9% | 9% | 8.4× | -17.9% | -1.3% |
| Cosmax 192820.KS | South Korea | $2.13B | +21% | +16% | 8% | 16.6× | n/a | n/a |
| KOSE 4922.T | Japan | $2.16B | +7% | +3% | 4% | 27.2× | n/a | n/a |
| Intercos ICOS.MI | Italy | $1.50B | +16% | -5% | 9% | 19.5× | 4.5% | +11.5% |
| Chongqing Baiya Sanitary Products 003006.SZ | China | $1.49B | +25% | 0% | 3% | 41.2× | 30.6% | +22.8% |
| Softcare 2698.HK | Hong Kong | $2.20B | -5% | +25% | 25% | 14.4× | 8.7% | +20.9% |
| Guangdong Marubi Biotechnology 603983.SS | China | $1.45B | -4% | -6% | 2% | 37.0× | n/a | n/a |
| Procter & Gamble Hygiene & Health Care PGHH.NS | India | $2.40B | -29% | -2% | 24% | 27.3× | 15.4% | +7.4% |
| d'Alba Global 483650.KS | South Korea | $1.32B | -37% | +55% | 21% | 13.6× | -2.2% | +53.0% |
| Edgewell Personal Care EPC | United States | $1.29B | +32% | -7% | 6% | 12.4× | 4.1% | +2.7% |
| LG H&h 051900.KS | South Korea | $2.56B | -8% | -3% | 3% | 18.5× | -0.1% | -4.1% |
| Gillette India GILLETTE.NS | India | $2.56B | -7% | +8% | 28% | 33.0× | 16.0% | +13.0% |